TABLE 2.
Delivery outcomes
Characteristic | 17-OHPC group (n=27) | No 17-OHPC group (n=52) | P value |
---|---|---|---|
Gestational age at delivery | 32.1±5.1 | 31.9±5.4 | .9 |
Spontaneous | 22 | 38 | |
Indicated | 5 | 14 | |
Delivery <34 wk | 17 | 27 | .47 |
Spontaneous | 16(59) | 24 (46) | |
Indicated | 1 (6) | 3(11) | |
Delivery <32 wk | 9 | 18 | .99 |
Spontaneous | 9(33) | 16(31) | .8 |
Indicated | 0(0) | 2(11) | |
Delivery <28 wk | 5 | 11 | .99 |
Spontaneous | 5(18) | 10(19) | .99 |
Indicated | 0(0) | 1 (9) | |
Delivery <24 wk | 3 | 7 | .99 |
Spontaneous | 3(11) | 7(13) | .99 |
Indicated | 0(0) | 0(0) | |
Mode of delivery | .99 | ||
Vaginal | 15 (56) | 29 (56) | |
Cesarean | 12 (44) | 23 (44) |
Data are expressed as n (%) and mean±standard deviation.
17-OHPC, 17-alpha-hydroxyprogesterone caproate.
Ward et al. 17-OHPC in twins and prior preterm birth. AJOG MFM 2020.